DE3673161D1 - Renininhibitoren und verfahren zur anwendung derselben. - Google Patents

Renininhibitoren und verfahren zur anwendung derselben.

Info

Publication number
DE3673161D1
DE3673161D1 DE8686308492T DE3673161T DE3673161D1 DE 3673161 D1 DE3673161 D1 DE 3673161D1 DE 8686308492 T DE8686308492 T DE 8686308492T DE 3673161 T DE3673161 T DE 3673161T DE 3673161 D1 DE3673161 D1 DE 3673161D1
Authority
DE
Germany
Prior art keywords
renine
inhibitors
renine inhibitors
rise
controlled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686308492T
Other languages
English (en)
Inventor
Robert Wayne Watkins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DE3673161D1 publication Critical patent/DE3673161D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/553—Renin inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/86—Renin inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8686308492T 1985-11-05 1986-10-31 Renininhibitoren und verfahren zur anwendung derselben. Expired - Fee Related DE3673161D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/795,282 US4906613A (en) 1985-11-05 1985-11-05 Antiglaucoma compositions and methods

Publications (1)

Publication Number Publication Date
DE3673161D1 true DE3673161D1 (de) 1990-09-06

Family

ID=25165170

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686308492T Expired - Fee Related DE3673161D1 (de) 1985-11-05 1986-10-31 Renininhibitoren und verfahren zur anwendung derselben.

Country Status (8)

Country Link
US (2) US4906613A (de)
EP (2) EP0246381B1 (de)
JP (1) JPS63501287A (de)
AT (1) ATE55054T1 (de)
DE (1) DE3673161D1 (de)
ES (1) ES2031822T3 (de)
GR (1) GR3000993T3 (de)
WO (1) WO1987002581A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4927807A (en) * 1987-10-06 1990-05-22 Abbott Laboratories Glaucoma treatment
US5036051A (en) * 1987-10-06 1991-07-30 Abbott Laboratories Glaucoma treatment
US5346887A (en) * 1987-10-06 1994-09-13 Abbott Laboratories Glaucoma treatment
GB8728561D0 (en) * 1987-12-07 1988-01-13 Glaxo Group Ltd Chemical compounds
GB8728560D0 (en) * 1987-12-07 1988-01-13 Glaxo Group Ltd Chemical compounds
ES2058489T3 (es) * 1988-01-26 1994-11-01 Sankyo Co Oligopeptidos con actividades inhibidoras de la renina, su preparacion y su uso.
US5059589A (en) * 1988-09-08 1991-10-22 Abbott Laboratories Glaucoma treatment
US5268374A (en) * 1988-10-04 1993-12-07 Abbott Laboratories Non-peptide renin inhibitors
IL92011A0 (en) * 1988-10-19 1990-07-12 Abbott Lab Heterocyclic peptide renin inhibitors
US5164388A (en) * 1988-10-19 1992-11-17 Abbott Laboratories Heterocyclic peptide renin inhibitors
JPH04502458A (ja) * 1988-12-22 1992-05-07 ジ・アップジョン・カンパニー レニン阻害性ペプチド類の経皮および鼻腔内投与
FR2647675B1 (fr) * 1989-06-05 1994-05-20 Sanofi Utilisation d'un derive de la statine dans le traitement des affections oculaires
US5063208A (en) * 1989-07-26 1991-11-05 Abbott Laboratories Peptidyl aminodiol renin inhibitors
US5688770A (en) * 1989-12-14 1997-11-18 Schering Corporation Antiglaucoma compositions and methods
US5182266A (en) * 1990-01-31 1993-01-26 Abbott Laboratories Method for treating renal disease
IE911326A1 (en) * 1990-04-23 1991-10-23 Abbott Lab Psoriasis treatment
IE68045B1 (en) * 1990-05-11 1996-05-15 Abbott Lab Renin inhibitors
US5332742A (en) * 1990-05-11 1994-07-26 Abbott Laboratories Renin inhibitors
JPH04243835A (ja) * 1990-08-29 1992-08-31 Pfizer Inc 高眼圧症又は緑内障治療用薬剤組成物及び治療方法
GB9127041D0 (en) * 1991-12-20 1992-02-19 Fujisawa Pharmaceutical Co New use
US6165490A (en) * 1996-04-05 2000-12-26 Staar Surgical Ag Biological material, method of preparing such materials, uses thereof and products made therefrom
US6420407B1 (en) 1999-09-16 2002-07-16 Gerald Horn Ophthalmic formulation which modulates dilation
US20020082288A1 (en) * 1999-09-16 2002-06-27 Gerald Horn Ophthalmic formulations comprising an imidazoline
US6291498B1 (en) 1999-09-16 2001-09-18 Gerald Horn Method for optimizing pupil size using alpha antagonist
US8889112B2 (en) * 1999-09-16 2014-11-18 Ocularis Pharma, Llc Ophthalmic formulations including selective alpha 1 antagonists
US6730065B1 (en) * 2000-09-15 2004-05-04 Ocularis Pharma, Inc. Night vision composition
US20060211753A1 (en) * 2000-11-03 2006-09-21 Ocularis Pharma, Inc. Method and composition which reduces stimulation of muscles which dilate the eye
AU2006261155A1 (en) 2005-06-17 2006-12-28 Regenerx Biopharmaceuticals, Inc. LKKTET and/or lKKTNT compositions and methods for treating or preventing tissue deterioration, injury or damage
US9089560B2 (en) 2013-02-01 2015-07-28 Ocularis Pharma, Llc Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance
DK2950648T3 (da) 2013-02-01 2019-12-02 Ocuphire Pharma Inc Vandige oftalmiske opløsninger af phentolamin og medicinske anvendelser deraf
KR20210096096A (ko) 2018-10-26 2021-08-04 오큐파이어 파마, 인크. 노안, 산동, 및 기타 안구 장애의 치료를 위한 방법 및 조성물
CA3168400A1 (en) 2020-02-19 2021-08-26 Vestlandets Innovasjonsselskap As Treatment of corneal vascularisation
CN115368310A (zh) 2021-05-18 2022-11-22 奥库菲尔医药公司 合成甲磺酸酚妥拉明的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985875A (en) * 1974-01-12 1976-10-12 Dainippon Pharmaceutical Co., Ltd. ω-(N-acylamino)alkylphosphoryl ethanolamines, pharmaceutical compositions containing them, and their uses
FR2399409A1 (fr) * 1977-08-04 1979-03-02 Anvar Nouveaux derives de la pepstatine, leur preparation et les compositions pharmaceutiques qui les contiennent
US4269827A (en) * 1980-06-23 1981-05-26 The Massachusetts General Hospital Process and composition for reducing blood pressure
NO812612L (no) * 1980-08-06 1982-02-08 Ferring Pharma Ltd Enzym-inhibitorer.
US4478826A (en) * 1981-10-08 1984-10-23 Merck & Co., Inc. Renin inhibitory peptides
US4384994A (en) * 1981-10-08 1983-05-24 Merck & Co., Inc. Renin inhibitory peptides
US4470971A (en) * 1981-10-19 1984-09-11 Merck & Co., Inc. Renin inhibitory peptides having His13
US4479941A (en) * 1981-12-10 1984-10-30 Merck & Co., Inc. Renin inhibitory peptides having PHE13 delection
FR2531951A1 (fr) * 1982-08-17 1984-02-24 Sanofi Sa Derives peptidiques inhibiteurs de proteases acides, procede pour leur preparation et medicaments qui en contiennent
US4478827A (en) * 1983-05-09 1984-10-23 The General Hospital Corporation Renin inhibitors
US4455303A (en) * 1983-05-24 1984-06-19 The General Hospital Corporation Renin inhibitors
US4485099A (en) * 1983-06-15 1984-11-27 Merck & Co., Inc. Renin inhibitors containing a C-terminal amide cycle
US4477441A (en) * 1983-09-14 1984-10-16 Merck & Co., Inc. Renin inhibitors containing a C-terminal disulfide cycle
US4477440A (en) * 1983-09-14 1984-10-16 Merck & Co., Inc. Renin inhibitors containing an n-terminal disulfide cycle
US4602093A (en) * 1984-02-08 1986-07-22 Merck & Co., Inc. Novel substituted imidazoles, their preparation and use
US4510085A (en) * 1984-04-12 1985-04-09 G.D. Searle & Co. Antihypertensive tetrapeptide amides
US4514332A (en) * 1984-04-16 1985-04-30 G. D. Searle & Co. Tetrapeptide adamantyl amides
US4574127A (en) * 1984-05-07 1986-03-04 Merck & Co., Inc. Oxazoles and thiazoles containing an aminohydroxypropoxyphenyl moiety
US4749698A (en) * 1985-07-08 1988-06-07 Rorer Pharmaceutical Corporation Antihypertensive derivatives

Also Published As

Publication number Publication date
ES2031822T3 (es) 1993-01-01
WO1987002581A1 (en) 1987-05-07
EP0246381A1 (de) 1987-11-25
GR3000993T3 (en) 1991-12-10
ATE55054T1 (de) 1990-08-15
JPS63501287A (ja) 1988-05-19
EP0243477A1 (de) 1987-11-04
US5352666A (en) 1994-10-04
EP0246381B1 (de) 1990-08-01
US4906613A (en) 1990-03-06

Similar Documents

Publication Publication Date Title
DE3673161D1 (de) Renininhibitoren und verfahren zur anwendung derselben.
ATE89738T1 (de) Antientzuendungsmittel.
DE3852697D1 (de) Verfahren und System zur Stromversorgungssteuerung eines Rechnersystems.
DE3688221D1 (de) Verfahren zur detektion und steuerung des anfangspunktes eines roboters.
ATA361585A (de) Verfahren und vorrichtung zur oberflaechenbehandlung von flaechigen werkstuecken
ES2097972T3 (es) Dispositivo para impedir la restenosis arterial.
DE3670341D1 (de) Verfahren und einrichtung zum kontrollieren des aufladedruckes eines turboladers.
DE69532279D1 (de) Methoden und zusammensetzung zur inhibition der angiogenese
DE69420371D1 (de) Vorrichtung und Verfahren zum Ultraschallversiegeln von Wegwerfwindeln
DE69422925T2 (de) Verfahren und vorrichtung für die transdermale oder transbuccale therapeutische verabreichung von nikotinsubstituten
DE69208412D1 (de) Verfahren und Einrichtung zur Luftdestillation und die Verwendung bei der Zuführung von Gas in Stahlwerken
DE68918191D1 (de) Verfahren zur Lactonisierung von Mevinsäuren und deren Analogen.
DE69522889D1 (de) Verfahren und Vorrichtung zum Regeln der Ausgangsleistung eines Leistungsverstärkers
DE3580109D1 (de) Verfahren und vorrichtung zum verteilenden zufuehren von gegenstaenden.
ATA344184A (de) Verfahren zur herstellung einer neuen, wasserfreien und stabilen deltakristallform von prazosinhydrochlorid
DE68928482D1 (de) Verfahren zur Herstellung eines Bipolartransistors
DE68917614D1 (de) Verfahren zum Ausrichten und zur Herstellung eines Verbindungszapfens.
DE69316806D1 (de) Vorrichtung zum axialen Ausrichten und zur Stosspositionierung von zwei länglichen Körpern
SE8803085L (sv) Dosform foer avgivande av diltiazem
DE68910287D1 (de) Castanospermin-ester zur Hemmung der Tumormetastasierung.
ATA106786A (de) Verfahren zur herstellung der neuen 7-amino-3propenylcephalosporansaeure sowie von estern und salzen derselben
DE68928787D1 (de) Verfahren zur Herstellung eines Bipolartransistors
DE3669733D1 (de) Verfahren und vorrichtung fuer anwendung mit ueberdruckreaktoren.
DE68912424D1 (de) Verfahren und Vorrichtung zum Anpassen der Funkenstrecke eines berührungsfreien Lithotriptors.
DE69310695T2 (de) Verfahren zur Steuerungshilfe eines tieffliegenden Flugkörpers

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee